RapidAI LVO alert gets Eric's artery reopened within 60 minutes

RapidAI's automated LVO alert mobilized the stroke team for Eric, 29; thrombectomy restored flow under 60 minutes from arrival; no deficits.

32ⓘ

AI system

System

RapidAI imaging platform (automated LVO detection)

Model

Not assessed

Release

Not assessed

Application developer

RapidAI

Role

Not assessed

Configuration

Not assessed

Inputs and outputs

Not assessed

Autonomy

Not assessed

Workflow

RapidAI LVO detection pushing alerts to the on-call neurointerventionalist's phone and watch. A comprehensive stroke center with an in-house thrombectomy team.

Human oversight

Not assessed

Relation to AI

RapidAI's automated LVO detection delivered the alert that prompted Dr Mehta to mobilize the cath lab team and fast-track thrombectomy. Under the Memorial stroke protocol EMS had already pre-notified the hospital and the neurointerventional team was ready before imaging. The occlusion would have been identified on the CT scan regardless. So the AI's contribution is speed at the point of care, and its share of the time saved cannot be separated from the pre-notification. The only counterfactual offered is Dr Mehta's general description of the pre-RapidAI workflow.

AI contribution

RapidAI's automated LVO detection delivered the alert that prompted Dr Mehta to mobilize the cath lab team and fast-track thrombectomy. Under the Memorial stroke protocol EMS had already pre-notified the hospital and the neurointerventional team was ready before imaging. The occlusion would have been identified on the CT scan regardless. So the AI's contribution is speed at the point of care, and its share of the time saved cannot be separated from the pre-notification. The only counterfactual offered is Dr Mehta's general description of the pre-RapidAI workflow.

Benefits

Outcome identifiers

Not assessed

Benefit

thrombectomy restored flow under 60 minutes from arrival; no deficits

Category

Improved Physical Health

Status

Not assessed

Beneficiary groups

People. Organizations.

Beneficiaries

Not assessed

Reach

Not assessed

Distribution and access

Not assessed

Duration

Not assessed

Expected?

Yes

Costs and harms

Not assessed

Measurement

Studies

Not assessed

Study design

Not assessed

Measurement

Not assessed

Setting and sample

Not assessed

Measures

thrombectomy restored flow under 60 minutes from arrival; no deficits

Comparison

Assumed alternative: the hospital's workflow before RapidAI, with scans viewed at workstations

Results

Assumed comparison. Reference: tethered to our workstations and had to take multiple steps to open the software to view the scans. Result: RapidAI alert on his smartphone and smartwatch; artery opened in under 60 minutes from arrival.

Additional value from AI

Not assessed

Limitations

Not assessed

Denominators

Not assessed

Materials for replication

Not assessed

Money

Kind of value

Not assessed

Amount

Not assessed

Currency and prices

Not assessed

Period and unit

Not assessed

Realization

Not assessed

Recipients and payers

Not assessed

Gross or net

Not assessed

Included costs

Not assessed

Comparison

Not assessed

Method

Not assessed

Return and payback

Not assessed

People and places

Participants

Developer: RapidAI. Operator: Memorial Healthcare System / Memorial Neuroscience Institute (Memorial Hospital West).

Jurisdictions

Developer: United States. Operator: United States.

Ownership and control

Not assessed

Dependencies

Not assessed

Cross-border connections

Not assessed

Geopolitical implications

Not assessed

Follow-up

Conditions for replication

Rapid recognition of stroke signs and EMS transport to a thrombectomy-capable center. Team mobilization on the AI alert rather than after a formal radiology read.

Replication attempts

Not assessed

Later findings

The release mentions only the platform's spread to three more Memorial hospitals since a 2017 trial, which predates this case; nothing later was found.

Availability

Not assessed

Institutional decision

Not assessed

Grounds

Not assessed

Action and result

Not assessed

Success criterion

Not assessed

Evidence

Source numbers

AIBD-0079-source-0001–0003

Citations

Numbered references below.

Language

Not assessed

Source relationships

Operator

Original evidence

Not assessed

Access and versions

Not assessed

Supported findings

Not assessed

Evidence strength

Not assessed

Missing evidence

Not assessed

Grades

Assessed benefits

People. Organizations.

Depth

People: 3. Organizations: 2.

Reasons

People: A 29-year-old had his occluded artery reopened within 60 minutes of arrival and reports being alive with no deficits. The AI's share is the time saved in fast-tracking the cath lab team after EMS had already pre-notified the hospital and the team was ready. The thrombectomy was the treatment. Organizations: Dr Mehta states that the platform streamlines workflow and cuts time compared with the previous need to open scans at workstations.

Observed or intended

Not assessed

Rubric

Not assessed

Assessor and date

Not assessed

Alternative assessments

Not assessed

Fill

The deployer's account

Entry details

Kind

Not assessed

Field

Healthcare - acute stroke care. Comprehensive stroke center AI triage.

Purpose

RapidAI's platform is built to detect large vessel occlusion on imaging and push alerts to the stroke team so that thrombectomy can start sooner. This is its intended function.

Dates

Date basis unassessed: 2022 (precision unassessed). Updated: 21 October 2026.

Stage

Not assessed

Version

SHA-256: 1067971966d0…

References

Other identifiers

Not assessed

Category mappings

Not assessed

Brief

Not assessed

Revisions

6 revisions. Latest: 21 October 2026.

Sources

  1. Press release Deployer

    Memorial Healthcare System (2022). Memorial Neuroscience Institute Uses AI to Optimize Care and Positive Outcomes for Stroke Patients. Hospital news release, 12 May 2022, quoting Dr Brijesh P. Mehta, medical director of the Comprehensive Stroke Program and Neurointerventional Surgery at Memorial Neuroscience Institute, and the patient.